TAPI is the leading international supplier of active pharmaceutical ingredients and Research & Development is one of the key reasons. More than 800 top scientists in TAPI’s seven development centers worldwide are always innovating. They specialize in chemical synthesis, fermentation, high potency, plant extraction, synthetic peptides, vitamin D derivatives, prostaglandins, and analytical and solid-state R&D.
Our significant investment in Research & Development generates a steady flow of API compounds, enabling customers to go to market with new pharmaceutical products more quickly. About half of TAPI’s R&D is dedicated to improving process efficiency and automation, to help customers reduce costs and remain competitive in the global marketplace.